Concepedia

Rezk R. Ayyad

RR

Statistics

Publications

34

Citations

1.7K

H-Index

25

Active since

2011

Affiliations

Al-Azhar University(Current)

King Saud University

Mansoura University

Delta University for Science and Technology

National Research Centre

Rezk R. Ayyad is an author at Al-Azhar University specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

2011–2023

34

Publications

34

Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4(3H)-quinazolinones

Alaa A.‐M. Abdel‐Aziz, Laila Abou‐Zeid, Kamal E. H. ElTahir et al. · European Journal of Medicinal Chemistry · 2016 · 112 citations · Full text

, , +12

Synthesis and antitumor evaluation of trimethoxyanilides based on 4(3H)-quinazolinone scaffolds

Menshawy A. Mohamed, Rezk R. Ayyad, Taghreed Z. Shawer et al. · European Journal of Medicinal Chemistry · 2016 · 98 citations

, , +14

Increasing the binding affinity of VEGFR-2 inhibitors by extending their hydrophobic interaction with the active site: Design, synthesis and biological evaluation of 1-substituted-4-(4-methoxybenzyl)phthalazine derivatives

Wagdy M. Eldehna, Sahar M. Abou‐Seri, Ahmed M. El Kerdawy et al. · European Journal of Medicinal Chemistry · 2016 · 96 citations · Full text

, , +17

Design, synthesis, and anti-proliferative evaluation of new quinazolin-4(3H)-ones as potential VEGFR-2 inhibitors

Khaled El‐Adl, Abdel‐Ghany A. El‐Helby, Rezk R. Ayyad et al. · Bioorganic & Medicinal Chemistry · 2020 · 94 citations · Full text

, , +12

Design, Synthesis, Molecular Docking, and Anticancer Activity of Phthalazine Derivatives as VEGFR‐2 Inhibitors

Abdel‐Ghany A. El‐Helby, Rezk R. Ayyad, Helmy Sakr et al. · Archiv der Pharmazie · 2017 · 87 citations

, , +14

1–5 of 34